New combo therapy aims to tame multiple food allergies at once
Disease control
Completed
This study tested whether a drug called omalizumab can make oral immunotherapy (OIT) safer for people allergic to two or more foods. Sixty participants aged 2 to 25 received OIT for multiple allergens along with omalizumab. The goal was to see if this combination allows lower mai…
Phase: PHASE2 • Sponsor: Andrew Long, PharmD • Aim: Disease control
Last updated May 17, 2026 17:06 UTC